Prospective analysis of 895 patients on a UK Genomics Review Board
More about Open Access at the CrickAuthors list
DA Moore M Kushnir G Mak H Winter T Curiel M Voskoboynik M Moschetta N Rozumna-Martynyuk K Balbi P Bennett M Forster A Kulkarni D Haynes Charles Swanton H-T ArkenauAbstract
The increasing frequency and complexity of cancer genomic profiling represents a challenge for the oncology community. Results from next-generation sequencing-based clinical tests require expert review to determine their clinical relevance and to ensure patients are stratified appropriately to established therapies or clinical trials.
Full text links
Publisher website (DOI) 10.1136/esmoopen-2018-000469
Figshare View on figshare
Europe PubMed Central 31245058
Pubmed 31245058